A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Active, not recruiting · NCT06818812 · Registry updated 2026-08-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Active, not recruiting | Phase 1 | 2026-08-25 | NCT06818812 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Incyte Corporation | 153 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Florida Cancer Specialists | Sarasota | United States | 47 |
| Georgetown University Hospital | Washington D.C. | United States | 14 |
| Hackensack University Medical Center | Hackensack | United States | 308 |
| Jefferson University Hospitals | Philadelphia | United States | 3 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| Sarah Cannon Research Institue At Healthone | Denver | United States | 2 |
| Scri Oncology Partners | Nashville | United States | 156 |
| Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins | Baltimore | United States | 1 |
| UCLA Healthcare Hematology-Oncology | Santa Monica | United States | 3 |